TE_37988
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 457.60 |
| Counts of samples | TCGA_tumor:405; TCGA_normal:0; GTEx:0 |
| TSS | chrX(-):86970011 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_37988.1 | - | Intergenic | Non-coding | Non-coding | chrX(-):86812997,86813017,86813122,86813212,86813704,86813853,86906461,86906542,86969885,86970012 |
| teRNA_37988.2 | - | Intergenic | Non-coding | Non-coding | chrX(-):86904272,86904292,86906461,86906542,86969885,86970012 |
| teRNA_37988.3 | - | Intergenic | Non-coding | Non-coding | chrX(-):86867605,86867625,86906461,86906542,86969885,86970012 |
| teRNA_37988.4 | - | Intergenic | Non-coding | Non-coding | chrX(-):86812997,86813017,86813122,86813212,86813704,86813853,86906461,86906542,86969622,86969739,86969885,86970012 |
| teRNA_37988.5 | - | Intergenic | Non-coding | Non-coding | chrX(-):86952124,86952144,86969622,86969739,86969885,86970012 |
| teRNA_37988.6 | - | Intergenic | Non-coding | Non-coding | chrX(-):86856033,86856053,86906461,86906542,86969622,86969739,86969885,86970012 |
| teRNA_37988.7 | - | Intergenic | Non-coding | Non-coding | chrX(-):86952124,86952144,86953146,86953210,86969622,86969739,86969885,86970012 |
| teRNA_37988.8 | - | Intergenic | Non-coding | Non-coding | chrX(-):86812997,86813017,86813122,86813212,86813704,86813853,86969622,86969739,86969885,86970012 |
| teRNA_37988.9 | - | Intergenic | Non-coding | Non-coding | chrX(-):86954652,86954672,86969622,86969739,86969885,86970012 |
| teRNA_37988.10 | - | Intergenic | Non-coding | Non-coding | chrX(-):86950699,86950719,86969622,86969739,86969885,86970012 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
